The anti-apoptotic gene BCL-2 has been shown to be overexpressed in CLL and inhibits the activity of pro-apoptotic BH3-only family members, such as PUMA [40,41,42]. This evidence concerns the gene BCL2 and B-cell chronic lymphocytic leukemia.